ETF 2B70 ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD
Add to a list
To use this feature you must be a member
Log inSign up

News iShares Nasdaq US Biotechnology UCITS ETF - USD

ETF

2B70

IE00BYXG2H39

Real-time BOERSE MUENCHEN
Other stock markets
 10:47:04 28/05/2024 BST 		5-day change 1st Jan Change
5.9 EUR -0.34% Intraday chart for iShares Nasdaq US Biotechnology UCITS ETF - USD -0.50% +3.12%
2023 IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Declares Interim Dividend, Payable on 29 December 2023 CI
2022 IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Declares Interim Dividend, Payable on 30 December 2022 CI

All the latest ETF news

Foreigners boost India corporate debt buying before govt bond index inclusion RE
US equity funds see massive weekly inflows on rate cut expectations RE
AGF Systematic Emerging Markets Equity ETF Revises Final Distribution, Payable on May 24, 2024 CI
IShares Core Hang Seng Index ETF Announces Interim Ordinary Dividend for the Financial Year Ended 31 December 2024, Payable on 28 June 2024 CI
Global equity funds see strong weekly inflows on U.S. rate cut hopes RE
Ishares Hang Seng Tech ETF Announces Interim (Semi-Annual) Dividend for the Financial Year End 31 December 2024, Payable on June 28, 2024 CI
Smartshares to Appoint Blackrock as the Investment Manager for the Smartshares Global Government Bond ETF CI
US SEC approves exchange applications to list spot ether ETFs RE
US SECURITIES AND EXCHANGE COMMISSION APPROVES EXCHANGE APPLICAT… RE
ETF of the week: Utilities play a role in the emergence of the IA Our Logo
Bourse Direct: a new ETF offer with Amundi CF
IShares Premium Money Market ETF Announces Final May 2024 Cash Distribution, Payable on May 31, 2024 CI
EU markets offer growth opportunities for ETF business - VanEck RE
Two US asset managers launch weight-loss ETFs RE
Will the Ethereum ETF soon be approved? MT
More news

Description

IE00BYXG2H39
Total Expense Ratio 0.35%
Asset Class
Sector
Size
Currency
Provider
Underlying NASDAQ Biotechnology Net Total Return Index - USD

Features and characteristics

Jurisdiction
Replication Method
Replication Model
Date of creation
17/10/2017
Dividend Policy
Geographical Focus

Distribution

Retail investor
Qualified Investor

AuM evolution ( 29/04/2024 )

AuM (EUR) 421 M€
AuM 1M 432 M€
AuM 3 months 408 M€
AuM 6 months 329 M€
AuM 12 months 433 M€
  1. Stock Market
  2. ETF
  3. 2B70 ETF
  4. News iShares Nasdaq US Biotechnology UCITS ETF - USD